ImmunoPrecise Antibodies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch IPA and buy or sell other stocks, ETFs, and their options commission-free!About IPA
MindWalk Holdings Corp. is an AI-driven biotherapeutic research, technology, and scientifically robust life science company that discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production. It operates through the following geographical segments: United States of America, Europe, Canada, Australia, and Other.
CEOJennifer L. Bath, PhD
CEOJennifer L. Bath, PhD
Employees102
Employees102
HeadquartersAustin, Texas
HeadquartersAustin, Texas
Founded1983
Founded1983
Employees102
Employees102
IPA Key Statistics
Market cap86.77M
Market cap86.77M
Price-Earnings ratio-2.85
Price-Earnings ratio-2.85
Dividend yield—
Dividend yield—
Average volume391.00K
Average volume391.00K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.25
52 Week high$3.25
52 Week low$0.27
52 Week low$0.27
Stock Snapshot
As of today, ImmunoPrecise Antibodies(IPA) shares are valued at $1.88. The company's market cap stands at 86.77M, with a P/E ratio of -2.85.
On 2025-11-10, ImmunoPrecise Antibodies(IPA) stock opened at —, reached a high of —, and a low of —.
ImmunoPrecise Antibodies(IPA) shares are trading with a volume of 0, against a daily average of 391K.
In the last year, ImmunoPrecise Antibodies(IPA) shares hit a 52-week high of $3.25 and a 52-week low of $0.27.
In the last year, ImmunoPrecise Antibodies(IPA) shares hit a 52-week high of $3.25 and a 52-week low of $0.27.
People also own
Based on the portfolios of people who own IPA. This list is generated using Robinhood data, and it’s not a recommendation.